Interoception and learning: Import to understanding and treating diseases and psychopathologies

ACS Chemical Neuroscience

Volumn 5, Issue 8, 2014, Pages 624-631

  Bevins, Rick A ^a   Besheer, Joyce ^b  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

drug abuse; Interoceptive conditioning; neuropathologies; nicotine; panic disorder; psychopathologies; smoking

Indexed keywords

CONDITIONING; DRUG ABUSE; DRUG DEPENDENCE; HUMAN; INTEROCEPTION; LEARNING; MENTAL DISEASE; NONHUMAN; PANIC; PRIORITY JOURNAL; REVIEW; SMOKING; SMOKING CESSATION; STIMULUS RESPONSE; TOBACCO DEPENDENCE; TOBACCO USE; ANIMAL; BRAIN; DRUG EFFECTS; DRUG THERAPY; PANIC DISORDER; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; HUMANS; INTEROCEPTION; LEARNING; PANIC DISORDER; SMOKING;

EID: 84906255020     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn5001028     Document Type: Review

References (91)

1. Pavlov, I. P. (1927) Conditioned reflexes; an investigation of the physiological activity of the cerebral cortex, Oxford University Press, Humphrey Milford, London.
2. Pavlov, I. (1941) Conditioned reflexes and psychiatry. In Lectures on conditioned reflexes, International Publishers, New York.
3. Paulus, M. P., Tapert, S. F., and Schulteis, G. (2009) The role of interoception and alliesthesia in addiction Pharmacol., Biochem. Behav. 94, 1-7
4. Paulus, M. P. and Stein, M. B. (2010) Interoception in anxiety and depression Brain Struct. Funct. 214, 451-463
5. Paulus, M. P. (2007) Neural basis of reward and craving - A homeostatic point of view Dialogues Clin. Neurosci. 9, 379-387
6. Paulus, M. P. and Stewart, J. L. (2014) Interoception and drug addiction Neuropharmacology 76 (Pt B) 342-350
7. Craig, A. D. (2002) How do you feel? Interoception: the sense of the physiological condition of the body Nat. Rev. Neurosci 3, 655-666
8. Craig, A. D. (2009) How do you feel - now? The anterior insula and human awareness Nat. Rev. Neurosci. 10, 59-70
9. Deen, B., Pitskel, N. B., and Pelphrey, K. A. (2011) Three systems of insular functional connectivity identified with cluster analysis Cereb. Cortex 21, 1498-1506
10. Cauda, F., DAgata, F., Sacco, K., Duca, S., Geminiani, G., and Vercelli, A. (2011) Functional connectivity of the insula in the resting brain NeuroImage 55, 8-23
11. Cloutman, L. L., Binney, R. J., Drakesmith, M., Parker, G. J., and Lambon Ralph, M. A. (2012) The variation of function across the human insula mirrors its patterns of structural connectivity: evidence from in vivo probabilistic tractography NeuroImage 59, 3514-3521
12. Bykov, K. M. (1957) The cerebral cortex and the internal organs, Chemical Publishing Co., New York.
13. Doty, R. W. (1961) Conditioned reflexes formed and evoked by brain stimulation. In Electrical stimulation of the brain: An interdisciplinary survey of neurobehavioral integrative systems (Sheer, D. E., Ed.), pp 397-412, University of Texas Press, Austin, TX.
14. Meagher, M. W. (2010) Developing translational animal models of cancer-related fatigue. In Cancer Symptom Science: Measurement, Mechanisms, and Management (Cleeland, C., Fisch, M., and Dunn, A., Eds.), pp 124-141, Cambridge University Press, Cambridge.
15. Koroboki, E., Zakopoulos, N., Manios, E., Rotas, V., Papadimitriou, G., and Papageorgiou, C. (2010) Interoceptive awareness in essential hypertension Int. J. Psychophysiol. 78, 158-162
16. De Peuter, S., Van Diest, I., Vansteenwegen, D., Van den Bergh, O., and Vlaeyen, J. W. (2011) Understanding fear of pain in chronic pain: Interoceptive fear conditioning as a novel approach Eur. J. Pain 15, 889-894
17. Wylie, K. P. and Tregellas, J. R. (2010) The role of the insula in schizophrenia Schizophr. Res. 123, 93-104
18. Davidson, T. L. (1993) The nature and function of interoceptive signals to feed: toward integration of physiological and learning perspectives Psychol. Rev. 100, 640-657
19. Oldershaw, A., Hambrook, D., Stahl, D., Tchanturia, K., Treasure, J., and Schmidt, U. (2011) The socio-emotional processing stream in anorexia nervosa Neurosci. Biobehav. Rev. 35, 970-988
20. Bevins, R. A. and Murray, J. E. (2011) Internal stimuli generated by abused substances: Role of Pavlovian conditioning and its implications for drug addiction. In Associative Learning and Conditioning: Human and Non-Human Applications (Schachtman, T. R. and Reilly, S., Eds.), pp 270-289, Oxford University Press, New York.
21. Wise, R. A., Wang, B., and You, Z. B. (2008) Cocaine serves as a peripheral interoceptive conditioned stimulus for central glutamate and dopamine release PLoS One 3, e2846
22. Bouton, M. E., Mineka, S., and Barlow, D. H. (2001) A modern learning theory perspective on the etiology of panic disorder Psychol. Rev. 108, 4-32
23. Deacon, B. J., Lickel, J. J., Farrell, N. R., Kemp, J. J., and Hipol, L. J. (2013) Therapist perceptions and delivery of interoceptive exposure for panic disorder J. Anxiety Disord. 27, 259-264
24. Franklin, T., Wang, Z., Suh, J. J., Hazan, R., Cruz, J., Li, Y., Goldman, M., Detre, J. A., OBrien, C. P., and Childress, A. R. (2011) Effects of varenicline on smoking cue-triggered neural and craving responses Arch. Gen. Psychiatry 68, 516-526
25. Rose, J. E. (1996) Nicotine addiction and treatment Annu. Rev. Med. 47, 493-507
26. Tiffany, S. T., Warthen, M. W., and Goedeker, K. C. (2009) The functional significance of craving in nicotine dependence. In The motivational impact of nicotine and its role in tobacco use (Bevins, R. A., and Caggiula, A. R., Eds.), Nebraska Symposium on Motivation Vol. 55, pp 171-197, Springer, New York.
27. Bevins, R. A. (2009) Altering the motivational function of nicotine through conditioning processes. In The motivational impact of nicotine and its role in tobacco use (Bevins, R. A., and Caggiula, A. R., Eds.), Nebraska Symposium on Motivation Vol. 55, pp 111-129, Springer, New York.
28. Bevins, R. A. and Palmatier, M. I. (2004) Extending the role of associative learning processes in nicotine addiction Behav. Cognit. Neurosci. Rev. 3, 143-158
29. Perkins, K. A. (1999) Nicotine discrimination in men and women Pharmacol., Biochem. Behav. 64, 295-299
30. Besheer, J., Palmatier, M. I., Metschke, D. M., and Bevins, R. A. (2004) Nicotine as a signal for the presence or absence of sucrose reward: A Pavlovian drug appetitive conditioning preparation in rats Psychopharmacology (Berlin, Ger.) 172, 108-117
31. Pittenger, S. T. and Bevins, R. A. (2013) Interoceptive conditioning with a nicotine stimulus is susceptible to reinforcer devaluation Behav. Neurosci. 127, 465-473
32. Riley, A. L. and Baril, L. L. (1976) Conditioned Taste Aversions-Bibliography Anim. Learn. Behav. 4, S1-S13
33. Struthers, A. M., Wilkinson, J. L., Dwoskin, L. P., Crooks, P. A., and Bevins, R. A. (2009) Mecamylamine, dihydro-beta-erythroidine, and dextromethorphan block conditioned responding evoked by the conditional stimulus effects of nicotine Pharmacol., Biochem. Behav. 94, 319-328
34. Holladay, M. W., Dart, M. J., and Lynch, J. K. (1997) Neuronal nicotinic acetylcholine receptors as targets for drug discovery J. Med. Chem. 40, 4169-4194
35. Reichel, C. M., Murray, J. E., Barr, J. D., and Bevins, R. A. (2010) Extinction with varenicline and nornicotine, but not ABT-418, weakens conditioned responding evoked by the interoceptive stimulus effects of nicotine Neuropharmacology 58, 1237-1245
36. Mihalak, K. B., Carroll, F. I., and Luetje, C. W. (2006) Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors Mol. Pharmacol. 70, 801-805
37. Dwoskin, L. P. and Crooks, P. A. (2001) Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery J. Pharmacol. Exp. Ther. 298, 395-402
38. Wishka, D. G., Walker, D. P., Yates, K. M., Reitz, S. C., Jia, S., Myers, J. K., Olson, K. L., Jacobsen, E. J., Wolfe, M. L., Groppi, V. E., Hanchar, A. J., Thornburgh, B. A., Cortes-Burgos, L. A., Wong, E. H., Staton, B. A., Raub, T. J., Higdon, N. R., Wall, T. M., Hurst, R. S., Walters, R. R., Hoffmann, W. E., Hajos, M., Franklin, S., Carey, G., Gold, L. H., Cook, K. K., Sands, S. B., Zhao, S. X., Soglia, J. R., Kalgutkar, A. S., Arneric, S. P., and Rogers, B. N. (2006) Discovery of N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5- carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure - activity relationship J. Med. Chem. 49, 4425-4436
39. Wooters, T. E., Bevins, R. A., and Bardo, M. T. (2009) Neuropharmacology of the interoceptive stimulus properties of nicotine Curr. Drug Abuse Rev. 2, 243-255
40. Charntikov, S., Tracy, M. E., Zhao, C., Li, M., and Bevins, R. A. (2012) Conditioned response evoked by nicotine conditioned stimulus preferentially induces c-Fos expression in medial regions of caudate-putamen Neuropsychopharmacology 37, 876-884
41. Everitt, B. J. and Robbins, T. W. (2005) Neural systems of reinforcement for drug addiction: from actions to habits to compulsion Nat. Neurosci 8, 1481-1489
42. Ashare, R. L., Falcone, M., and Lerman, C. (2014) Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment Neuropharmacology 76 (Pt B) 581-591
43. Markou, A. and Paterson, N. E.. (2009) Multiple motivational forces contribute to nicotine dependence In The motivational impact of nicotine and its role in tobacco use (Bevins, R. A. and Caggiula, A. R., Eds.), Nebraska Symposium on Motivation Vol. 55, pp 65-89, Springer, New York.
44. Robbins, T. W. (2002) The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry Psychopharmacology (Berlin, Ger.) 163, 362-380
45. Shoaib, M. and Bizarro, L. (2005) Deficits in a sustained attention task following nicotine withdrawal in rats Psychopharmacology (Berlin, Ger.) 178, 211-222
46. Levin, E. D., McClernon, F. J., and Rezvani, A. H. (2006) Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization Psychopharmacology (Berlin, Ger.) 184, 523-539
47. Portugal, G. S. and Gould, T. J. (2007) Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioning Pharmacol., Biochem. Behav. 88, 179-187
48. Markou, A., Chiamulera, C., Geyer, M. A., Tricklebank, M., and Steckler, T. (2009) Removing obstacles in neuroscience drug discovery: the future path for animal models Neuropsychopharmacology 34, 74-89
49. Scammell, T. E., Estabrooke, I. V., McCarthy, M. T., Chemelli, R. M., Yanagisawa, M., Miller, M. S., and Saper, C. B. (2000) Hypothalamic arousal regions are activated during modafinil-induced wakefulness J. Neurosci. 20, 8620-8628
50. Ballon, J. S. and Feifel, D. (2006) A systematic review of modafinil: Potential clinical uses and mechanisms of action J. Clin. Psychiatry 67, 554-566
51. Wisor, J. P. and Eriksson, K. S. (2005) Dopaminergic-Adrenergic interactions in the wake promoting mechanism of modafinil Neuroscience 132, 1027-1034
52. Dopheide, M. M., Morgan, R. E., Rodvelt, K. R., Schachtman, T. R., and Miller, D. K. (2007) Modafinil evokes striatal [(3)H]dopamine release and alters the subjective properties of stimulants Eur. J. Pharmacol. 568, 112-123
53. Ferraro, L., Tanganelli, S., OConnor, W. T., Antonelli, T., Rambert, F., and Fuxe, K. (1996) The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism Eur. J. Pharmacol. 306, 33-39
54. Ferraro, L., Antonelli, T., OConnor, W. T., Tanganelli, S., Rambert, F. A., and Fuxe, K. (1998) The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: evidence for a preferential inhibition of striato-pallidal GABA transmission Neurosci. Lett. 253, 135-138
55. Perkins, K. A. and Lerman, C. (2014) An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation Psychopharmacology (Berlin, Ger.) 231, 1-11
56. Schnoll, R. A., Wileyto, E. P., Pinto, A., Leone, F., Gariti, P., Siegel, S., Perkins, K. A., Dackis, C., Heitjan, D. F., Berrettini, W., and Lerman, C. (2008) A placebo-controlled trial of modafinil for nicotine dependence Drug Alcohol Depend. 98, 86-93
57. Kessler, R. C., Chiu, W. T., Jin, R., Ruscio, A. M., Shear, K., and Walters, E. E. (2006) The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication Arch. Gen. Psychiatry 63, 415-424
58. Weissman, M. M., Bland, R. C., Canino, G. J., Faravelli, C., Greenwald, S., Hwu, H. G., Joyce, P. R., Karam, E. G., Lee, C. K., Lellouch, J., Lepine, J. P., Newman, S. C., Oakley-Browne, M. A., Rubio-Stipec, M., Wells, J. E., Wickramaratne, P. J., Wittchen, H. U., and Yeh, E. K. (1997) The cross-national epidemiology of panic disorder Arch. Gen. Psychiatry 54, 305-309
59. 2-induced fear by 5-HTTLPR genotype J. Psychopharmacol. 25, 37-42
60. Leibold, N. K., Viechtbauer, W., Goossens, L., De Cort, K., Griez, E. J., Myin-Germeys, I., Steinbusch, H. W., van den Hove, D. L., and Schruers, K. R. (2013) Carbon dioxide inhalation as a human experimental model of panic: the relationship between emotions and cardiovascular physiology Biol. Psychol. 94, 331-340
61. 2-enriched air as unconditioned stimuli J. Abnorm. Psychol. 107, 291-304
62. 2-enriched air inhalation Behav. Res. Ther. 33, 517-527
63. Acheson, D. T., Forsyth, J. P., Prenoveau, J. M., and Bouton, M. E. (2007) Interoceptive fear conditioning as a learning model of panic disorder: an experimental evaluation using 20% CO(2)-enriched air in a non-clinical sample Behav. Res. Ther. 45, 2280-2294
64. De Cort, K., Griez, E., Buchler, M., and Schruers, K. (2012) The role of "interoceptive" fear conditioning in the development of panic disorder Behav. Ther. 43, 203-215
65. Stegen, K., De Bruyne, K., Rasschaert, W., Van de Woestijne, K. P., and Van den Bergh, O. (1999) Fear-relevant images as conditioned stimuli for somatic complaints, respiratory behavior, and reduced end-tidal pCO2 J. Abnorm. Psychol. 108, 143-152
66. Forsyth, J. P., Eifert, G. H., and Thompson, R. N. (1996) Systemic alarms in fear conditioning 0.2. An experimental methodology using 20% carbon dioxide inhalation as an unconditioned stimulus Behav. Ther. 27, 391-415
67. Acheson, D. T., Forsyth, J. P., and Moses, E. (2012) Interoceptive fear conditioning and panic disorder: the role of conditioned stimulus-unconditioned stimulus predictability Behav. Ther. 43, 174-189
68. 2 and hyperventilation in patients with panic disorder Am. J. Psychiatry 151, 547-553
69. Griebel, G. and Holmes, A. (2013) 50 years of hurdles and hope in anxiolytic drug discovery Nat. Rev. Drug Discovery 12, 667-687
70. Sigurdsson, T., Doyere, V., Cain, C. K., and LeDoux, J. E. (2007) Long-term potentiation in the amygdala: a cellular mechanism of fear learning and memory Neuropharmacology 52, 215-227
71. Rosen, J. B. and Donley, M. P. (2006) Animal studies of amygdala function in fear and uncertainty: relevance to human research Biol. Psychol. 73, 49-60
72. Gorman, J. M., Kent, J. M., Sullivan, G. M., and Coplan, J. D. (2000) Neuroanatomical hypothesis of panic disorder, revised Am. J. Psychiatry 157, 493-505
73. Garakani, A., Mathew, S. J., and Charney, D. S. (2006) Neurobiology of anxiety disorders and implications for treatment Mt. Sinai J. Med. 73, 941-949
74. Johnson, P. L. and Shekhar, A. (2012) An animal model of panic vulnerability with chronic disinhibition of the dorsomedial/perifornical hypothalamus Physiol. Behav. 107, 686-698
75. Liebowitz, M. R., Gorman, J., Fyer, A., Levitt, M., Levy, G., Dillon, D., Appleby, I., Anderson, S., Palij, M., and Davies, S. O. (1984) Biological accompaniments of lactate-induced panic Psychopharmacol. Bull. 20, 43-44
76. Cowley, D. S., Dager, S. R., Roy-Byrne, P. P., Avery, D. H., and Dunner, D. L. (1991) Lactate vulnerability after alprazolam versus placebo treatment of panic disorder Biol. Psychiatry 30, 49-56
77. Jensen, C. F., Peskind, E. R., Keller, T. W., McFall, M. E., and Raskind, M. A. (1998) Comparison of sodium lactate-induced panic symptoms between panic disorder and posttraumatic stress disorder Depression Anxiety 7, 122-125
78. Goetz, R. R., Klein, D. F., and Gorman, J. M. (1996) Symptoms essential to the experience of sodium lactate-induced panic Neuropsychopharmacology 14, 355-366
79. Johnson, P. L. and Shekhar, A. (2006) Panic-prone state induced in rats with GABA dysfunction in the dorsomedial hypothalamus is mediated by NMDA receptors J. Neurosci. 26, 7093-7104
80. Shekhar, A. and Keim, S. R. (2000) LY354740, a potent group II metabotropic glutamate receptor agonist prevents lactate-induced panic-like response in panic-prone rats Neuropharmacology 39, 1139-1146
81. Johnson, P. L., Fitz, S. D., Engleman, E. A., Svensson, K. A., Schkeryantz, J. M., and Shekhar, A. (2013) Group II metabotropic glutamate receptor type 2 allosteric potentiators prevent sodium lactate-induced panic-like response in panic-vulnerable rats J. Psychopharmacol. 27, 152-161
82. Johnson, P. L., Truitt, W., Fitz, S. D., Minick, P. E., Dietrich, A., Sanghani, S., Traskman-Bendz, L., Goddard, A. W., Brundin, L., and Shekhar, A. (2010) A key role for orexin in panic anxiety Nat. Med. 16, 111-115
83. Mitte, K. (2005) A meta-Analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia J. Affective Disord. 88, 27-45
84. Andrisano, C., Chiesa, A., and Serretti, A. (2013) Newer antidepressants and panic disorder: a meta-Analysis Int. Clin. Psychopharmacol. 28, 33-45
85. van Balkom, A. J., Bakker, A., Spinhoven, P., Blaauw, B. M., Smeenk, S., and Ruesink, B. (1997) A meta-Analysis of the treatment of panic disorder with or without agoraphobia: a comparison of psychopharmacological, cognitive-behavioral, and combination treatments J. Nerv. Ment. Dis. 185, 510-516
86. Schmidt, N. B. and Trakowski, J. (2004) Interoceptive assessment and exposure in panic disorder: A descriptive study Cognit. Behav. Pract. 11, 81-92
87. Antony, M. M., Ledley, D. R., Liss, A., and Swinson, R. P. (2006) Responses to symptom induction exercises in panic disorder Behav. Res. Ther. 44, 85-98
88. Lee, K., Noda, Y., Nakano, Y., Ogawa, S., Kinoshita, Y., Funayama, T., and Furukawa, T. A. (2006) Interoceptive hypersensitivity and interoceptive exposure in patients with panic disorder: Specificity and effectiveness BMC Psychiatry 6, 32
89. Norberg, M. M., Krystal, J. H., and Tolin, D. F. (2008) A meta-Analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy Biol. Psychiatry 63, 1118-1126
90. Otto, M. W., Tolin, D. F., Simon, N. M., Pearlson, G. D., Basden, S., Meunier, S. A., Hofmann, S. G., Eisenmenger, K., Krystal, J. H., and Pollack, M. H. (2010) Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder Biol. Psychiatry 67, 365-370
91. Fadel, J. and Burk, J. A. (2010) Orexin/hypocretin modulation of the basal forebrain cholinergic system: Role in attention Brain Res. 1314, 112-123